Albert Bourla

Età : 60

Patrimonio pubblico : 21 317 685 USD

Paese di residenza : Unknown

Principali società :

Pfizer Inc.

Biografia di Albert Bourla

Albert Bourla è presidente, amministratore delegato e direttore operativo di Pfizer Inc., membro di The Business Roundtable e membro di The Business Council e nel consiglio di amministrazione di altre 7 società. Il dottor Bourla ha ricevuto un dottorato dalla Scuola di medicina veterinaria (Grecia).

Posti e reponsabilità di Albert Bourla

Nome	Titolo	Da
Pfizer Inc. (Prodotti farmaceutici)	Chairman, Chief Executive & Operating Officer	2020
International Federation of Pharmaceutical Manufacturers	Vice President	-
Biotechnology Innovation Organization	Director	-
Catalyst, Inc.	Director	2019
The Partnership for New York City, Inc.	Director	-
Pharmaceutical Research & Manufacturers of America	Director	-
Healthcare Leadership Council	Director	-
The Pfizer Foundation, Inc.	Director	-
United States Council for International Business	Trustee	-
The Business Roundtable	Member	-
The Business Council	Member	-

Participazioni di Albert Bourla

Nome	Azioni	%	Valorizzazione
Pfizer, Inc. (PFE) (Prodotti farmaceutici)	416 036	0,0074%	21 317 685 USD

Albert Bourla : network personale

Nome	Società collegate
Ian Read	Pfizer Inc. International Federation of Pharmaceutical Manufacturers The Partnership for New York City, Inc. United States Council for International Business Catalyst, Inc. Pharmaceutical Research & Manufacturers of America Healthcare Leadership Council
James R. Quincey	Pfizer Inc. The Business Roundtable Catalyst, Inc.
Angela Hwang	Pfizer Inc. The Pfizer Foundation, Inc.
Sally Susman	Pfizer Inc. The Pfizer Foundation, Inc.
David Ricks	International Federation of Pharmaceutical Manufacturers The Business Council The Business Roundtable Pharmaceutical Research & Manufacturers of America
Susan D. Desmond-Hellmann	Pfizer Inc. Biotechnology Innovation Organization
Dan R. Littman	Pfizer Inc.
Deborah Baron	Pfizer Inc.
Aida Habtezion	Pfizer Inc.
Joseph Echevarria	Pfizer Inc.